AMN

Trent-Adams Sylvia

Known title: DirectorCIK: 0001826381

Trent-Adams Sylvia's purchase track record

Trent-Adams Sylvia has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.

PurchaseStockAmount3 months6 months
2/28/2024AMN$10K-3.3%-5.1%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 14, 2026

AMN Healthcare Maintains Outperform Rating, Target Raised to $43. Analyst BMO Capital kept an Outperform rating on AMN Healthcare and increased its price target to $43. The company announced a third‑quarter 2026 earnings conference call scheduled for November 5. The stock trades near its $33.96 support level and carries a trailing P/E of 13.4, while analysts’ average target is $36.14.

this person other insiders at AMN

Transaction History

AMN▲ Buy$0
AMN▲ Buy$0
AMN▲ Buy$0
AMN▲ Buy$10K
AMN▲ Buy$0
AMN▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.